Fresenius Medical Care (NYSE:FMS) Shares Gap Up to $19.54

Shares of Fresenius Medical Care AG (NYSE:FMS - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $19.54, but opened at $20.66. Fresenius Medical Care shares last traded at $20.68, with a volume of 272,203 shares.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on FMS shares. Morgan Stanley cut Fresenius Medical Care from an "equal weight" rating to an "underweight" rating in a report on Monday, January 8th. StockNews.com raised shares of Fresenius Medical Care from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 16th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $32.25.

Fresenius Medical Care Trading Up 5.2 %

The company has a market capitalization of $12.06 billion, a PE ratio of 22.34, a price-to-earnings-growth ratio of 0.96 and a beta of 1.00. The company has a quick ratio of 1.07, a current ratio of 1.42 and a debt-to-equity ratio of 0.47. The stock's fifty day moving average price is $19.53 and its two-hundred day moving average price is $19.45.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.11. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.32 billion. Fresenius Medical Care had a return on equity of 4.99% and a net margin of 2.56%. Sell-side analysts anticipate that Fresenius Medical Care AG will post 1.51 earnings per share for the current year.

Fresenius Medical Care Cuts Dividend

The business also recently announced an annual dividend, which will be paid on Monday, June 3rd. Stockholders of record on Monday, May 20th will be given a $0.437 dividend. The ex-dividend date is Friday, May 17th. This represents a dividend yield of 2.35%. Fresenius Medical Care's dividend payout ratio is 45.65%.

Hedge Funds Weigh In On Fresenius Medical Care

Hedge funds and other institutional investors have recently modified their holdings of the stock. Pacer Advisors Inc. boosted its stake in Fresenius Medical Care by 14,252.1% during the fourth quarter. Pacer Advisors Inc. now owns 488,401 shares of the company's stock worth $10,173,000 after acquiring an additional 484,998 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in shares of Fresenius Medical Care by 362.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 259,033 shares of the company's stock worth $5,580,000 after buying an additional 202,991 shares during the last quarter. Moran Wealth Management LLC bought a new position in Fresenius Medical Care during the 4th quarter valued at approximately $3,247,000. Partnership Wealth Management LLC purchased a new position in Fresenius Medical Care during the fourth quarter valued at $2,340,000. Finally, O Shaughnessy Asset Management LLC boosted its holdings in Fresenius Medical Care by 259.5% in the third quarter. O Shaughnessy Asset Management LLC now owns 92,635 shares of the company's stock worth $1,995,000 after acquiring an additional 66,864 shares in the last quarter. Hedge funds and other institutional investors own 8.25% of the company's stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.